Yawei Yuan

1.7k total citations
73 papers, 1.2k citations indexed

About

Yawei Yuan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yawei Yuan has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 30 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yawei Yuan's work include Head and Neck Cancer Studies (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer-related molecular mechanisms research (10 papers). Yawei Yuan is often cited by papers focused on Head and Neck Cancer Studies (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer-related molecular mechanisms research (10 papers). Yawei Yuan collaborates with scholars based in China, United States and India. Yawei Yuan's co-authors include Jie Lin, Baiyao Wang, Muhammad Khan, Yingying Liang, Rong Li, Yunhong Tian, Mengzhong Liu, Guixiang Liao, Yunhong Tian and Jieling Zheng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yawei Yuan

71 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yawei Yuan China 22 600 398 372 343 144 73 1.2k
Annett Linge Germany 15 445 0.7× 321 0.8× 238 0.6× 160 0.5× 83 0.6× 42 893
Ye Tian China 18 382 0.6× 191 0.5× 246 0.7× 229 0.7× 61 0.4× 79 867
Dean B. Reardon United States 18 791 1.3× 595 1.5× 232 0.6× 315 0.9× 62 0.4× 23 1.4k
Defeng Deng United States 18 703 1.2× 476 1.2× 362 1.0× 128 0.4× 280 1.9× 29 1.3k
M. Ratcliffe United Kingdom 20 619 1.0× 680 1.7× 411 1.1× 661 1.9× 198 1.4× 47 1.6k
San‐Gang Wu China 15 206 0.3× 270 0.7× 365 1.0× 197 0.6× 57 0.4× 41 886
Jia‐Jie Hao China 22 919 1.5× 358 0.9× 459 1.2× 284 0.8× 118 0.8× 58 1.4k
Ludmilla Thomé Domingos Chinen Brazil 19 1.1k 1.8× 811 2.0× 971 2.6× 448 1.3× 77 0.5× 58 2.0k

Countries citing papers authored by Yawei Yuan

Since Specialization
Citations

This map shows the geographic impact of Yawei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Yuan more than expected).

Fields of papers citing papers by Yawei Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Yuan. The network helps show where Yawei Yuan may publish in the future.

Co-authorship network of co-authors of Yawei Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Yawei Yuan. A scholar is included among the top collaborators of Yawei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawei Yuan. Yawei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yan, Ye Chen, R. Yu, et al.. (2024). A Phase II Clinical Trial of Sintilimab Combined with Lower Dose Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 120(2). e433–e434. 1 indexed citations
2.
Sun, Ying, Ye‐Lin Liang, Liangfang Shen, et al.. (2024). PD-1 blockade with camrelizumab after chemoradiotherapy in nasopharyngeal carcinoma.. Journal of Clinical Oncology. 42(23_suppl). 129–129. 1 indexed citations
3.
Ma, Jun, Ying Sun, Ye‐Lin Liang, et al.. (2024). Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial.. Journal of Clinical Oncology. 42(17_suppl). LBA6000–LBA6000. 13 indexed citations
4.
Xu, Anan, Jingjing Miao, Lin Wang, et al.. (2023). Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis. Radiation Oncology. 18(1). 63–63. 4 indexed citations
5.
6.
Xie, Tao, Kunpeng Du, Wei Liu, et al.. (2022). LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis. British Journal of Cancer. 127(7). 1239–1253. 6 indexed citations
7.
Wang, Baiyao, Xiaoting Huang, Hongli Yang, et al.. (2021). PLK1 Inhibition Sensitizes Breast Cancer Cells to Radiation via Suppressing Autophagy. International Journal of Radiation Oncology*Biology*Physics. 110(4). 1234–1247. 42 indexed citations
8.
Khan, Muhammad, Sumbal Arooj, Rong Li, et al.. (2020). Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases. Frontiers in Oncology. 10. 781–781. 17 indexed citations
9.
Wang, Xuejun, et al.. (2020). Cutaneous Metastasis as the First Presentation of Non-Small-Cell Lung Cancer with a BRAF Mutation: A Case Report. OncoTargets and Therapy. Volume 13. 13143–13149. 2 indexed citations
10.
Huang, Chunyue, Yujia Zhu, Hongmei Wang, et al.. (2020). Comparison of a Concurrent Fluorouracil-Based Regimen and a Taxane-Based Regimen Combined with Radiotherapy in Elderly Patients with Esophageal Squamous Cell Carcinoma. Translational Oncology. 13(3). 100736–100736. 8 indexed citations
11.
Xu, Anan, Rong Li, Zhong Huang, et al.. (2020). Regulatory coupling between long noncoding RNAs and senescence in irradiated microglia. Journal of Neuroinflammation. 17(1). 321–321. 11 indexed citations
12.
13.
Weng, Ching‐Feng, Yubin Wu, Hua Mao, et al.. (2019). Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Zhang, Jiän, Zi‐Qi Zheng, Yawei Yuan, et al.. (2019). NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription. Neoplasia. 21(3). 311–321. 13 indexed citations
15.
Khan, Muhammad, Jie Lin, Guixiang Liao, et al.. (2019). Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors. Frontiers in Oncology. 9. 205–205. 16 indexed citations
16.
Zhang, Jiän, Tao Xie, Jieling Zheng, et al.. (2019). The Tumor Suppressor Role of Zinc Finger Protein 671 (ZNF671) in Multiple Tumors Based on Cancer Single-Cell Sequencing. Frontiers in Oncology. 9. 1214–1214. 16 indexed citations
17.
Wang, Baiyao, Jieling Zheng, Rong Li, et al.. (2019). Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells. Cell Death and Disease. 10(10). 764–764. 68 indexed citations
18.
Chen, Yong, Yong Wu, Xia Liu, et al.. (2019). <p>Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53</p>. OncoTargets and Therapy. Volume 12. 2553–2561. 28 indexed citations
19.
Sun, Quanquan, Liu Xiong, Ying Liu, et al.. (2011). [Effect of shRNAmir lentiviral vector-mediated COX-2 silencing on the radiosensitivity of nasopharyngeal carcinoma cells].. PubMed. 31(4). 599–603. 1 indexed citations
20.
Banerjee, Abhijit G., Jie Liu, Yawei Yuan, et al.. (2003). Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.. Molecular Cancer. 2(1). 34–34. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annett Linge Breakdown of academic impact, for papers by Ye Tian Breakdown of academic impact, for papers by Dean B. Reardon Breakdown of academic impact, for papers by Defeng Deng Breakdown of academic impact, for papers by M. Ratcliffe Breakdown of academic impact, for papers by San‐Gang Wu Breakdown of academic impact, for papers by Jia‐Jie Hao Breakdown of academic impact, for papers by Ludmilla Thomé Domingos Chinen
Rankless by CCL
2026